Sign in
Taking people in United StatesNo phase

Social Functioning in Opioid Use Disorder

Key facts

Who runs it
Medical University of South Carolina
Where
Charleston, United StatesSee the site
Trial code
Status
Recruiting
People taking part
230 people, planned
Started
13 Aug 2026
Expected to end
31 Aug 2029
Type of study
Interventional
Treatments tested
  • CBT4CBT-Buprenorphine
Record updated
17 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Any sex or gender; any race or ethnicity; aged 18 years or older
  • Patient participants must meet DSM-5 diagnostic criteria for current (i.e., past 12 months) OUD (assessed via the Quick Structured Clinical Interview for DSM-5; Quick SCID)
  • Patient participants must be on medication for opioid use disorder (MOUD), as prescribed by their provider, for no more than 12 weeks prior to study initiation
  • Patient participants must be in treatment at a clinic in South Carolina
  • Concurrent substance use disorders (e.g., alcohol, cannabis) for the patient participant are acceptable, provided opioids are the patient participant's primary substance of choice
  • Patient participants must identify a CSO participant who consents to participation in the study as well

Who cannot take part

  • Meeting DSM-5 criteria for a history of or current psychotic or bipolar disorders
  • CSO participants meeting DSM-5 criteria for opioid use disorder or any other substance use disorder, excepting tobacco use disorder, mild cannabis use disorder, and mild alcohol use disorder
  • Moderate-to-severe opioid withdrawal as defined by a score of ≥21 on the Subjective Opioid Withdrawal Scale
  • Current suicidal or homicidal ideation and intent; participants who present a serious suicide risk are likely to require hospitalization during the study and they will be referred clinically
  • Severe interpersonal violence in the past six months between the patient and the CSO, as defined by an adapted version of the Conflict Tactics Scaled Revised (CTS-2)
  • Pregnancy for patient participants
  • Prisoners, institutional individuals, and children will not be recruited for this study

This trial is currently available in United States.

  • Medical University of South CarolinaCharleston, United StatesContact: Amber Jarnecke, PhDTaking people

About the trial

What the trial wants to find out

Problems with social functioning are core to opioid use disorder (OUD), though specific, modifiable social functioning targets and how they relate to OUD treatment outcomes are poorly understood. This study will utilize both data from both patients with OUD and their concerned significant other (CSO) to examine associations between specific social functioning metrics and OUD treatment outcomes. Findings from this study will inform future precision-medicine approaches for people with OUD, a population in significant need of enhanced treatment approaches to combat opioid morbidity and mortality.

The group in the trial

  • CBT4CBT-BuprenorphineTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Real-world Assessment of Social Functioning During OUD Treatment: Integrating Reports From Patients and Their Concerned Significant Others
Record updated
17 August 2026